The regulatory path is clear for Hologic to begin marketing its SecurViewDX breast imaging workstation. The FDA earlier this month cleared the dedicated workstation for display and interpretation of screening and diagnostic digital mammograms, as well as
The regulatory path is clear for Hologic to begin marketing its SecurViewDX breast imaging workstation. The FDA earlier this month cleared the dedicated workstation for display and interpretation of screening and diagnostic digital mammograms, as well as other images such as MRI, CT, PET, and ultrasound. The workstation can also support digital CAD programs. It will complement Hologic's Lorad Selenia full-field digital mammography system, but its use will not be restricted to this system. The SecurViewDX is FDA cleared as an adjunct to any FDA-approved FFDM system.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.